PMID: 10970190

Boyne J, Evans S, Pollitt RJ, Taylor CJ, Dalton A
Many deltaF508 heterozygote neonates with transient hypertrypsinaemia have a second, mild CFTR mutation.
J Med Genet. 2000 Jul;37(7):543-7., [PubMed]
Sentences
No. Mutations Sentence Comment
509 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10970190:509:169
status: NEW
view ABCC7 p.Arg117His details
In addition, three transiently hypertrypsinaemic babies who would otherwise have qualified for the cohort had already been identified as compound heterozygotes for F508/R117H CF mutations through extended mutation analysis of their parents. Login to comment
522 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10970190:522:0
status: NEW
view ABCC7 p.Arg117His details
R117H was the most common second mutation found, constituting 45% of the compound heterozygotes identified. Login to comment
526 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10970190:526:260
status: NEW
view ABCC7 p.Arg117His details
Recent work has suggested that "polyvariant mutant CFTR genes" may, when combined, result in less functional or pathologically insuYcient CFTR.21 In the light of this, we determined the incidence of the intronic poly-T tract, IVS8-nT, which interacts with the R117H mutation. Login to comment
532 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10970190:532:110
status: NEW
view ABCC7 p.Arg117His details
In general, the severity of lung disease is less predictable than the degree of pancreatic involvement.22 The R117H has been associated with a range of phenotypes and the intronic variant polyT tract (IVS8-nT) is known to aVect expression. Login to comment
533 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10970190:533:66
status: NEW
view ABCC7 p.Arg117His details
The IVS8-5T variant is an ineYcient splice acceptor site and with R117H, in trans with F508, results in a pancreatic suYcient phenotype. Login to comment
534 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10970190:534:19
status: NEW
view ABCC7 p.Arg117His details
The 7T variant and R117H combination in F508 heterozygotes is associated with congenital bilateral absence of the vas deferens and, in some cases, mild lung disease.19 23 Some females with this genotype are completely asymptomatic. Login to comment
538 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10970190:538:290
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10970190:538:311
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10970190:538:330
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10970190:538:349
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10970190:538:369
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10970190:538:389
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10970190:538:410
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10970190:538:430
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10970190:538:450
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Pro67Leu
X
ABCC7 p.Pro67Leu 10970190:538:270
status: NEW
view ABCC7 p.Pro67Leu details
ABCC7 p.Arg117Leu
X
ABCC7 p.Arg117Leu 10970190:538:471
status: NEW
view ABCC7 p.Arg117Leu details
ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 10970190:538:512
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Arg75*
X
ABCC7 p.Arg75* 10970190:538:581
status: NEW
view ABCC7 p.Arg75* details
ABCC7 p.Arg75*
X
ABCC7 p.Arg75* 10970190:538:599
status: NEW
view ABCC7 p.Arg75* details
ABCC7 p.Arg1066His
X
ABCC7 p.Arg1066His 10970190:538:535
status: NEW
view ABCC7 p.Arg1066His details
ABCC7 p.Arg851*
X
ABCC7 p.Arg851* 10970190:538:618
status: NEW
view ABCC7 p.Arg851* details
ABCC7 p.Leu967Ser
X
ABCC7 p.Leu967Ser 10970190:538:491
status: NEW
view ABCC7 p.Leu967Ser details
ABCC7 p.Phe693Leu
X
ABCC7 p.Phe693Leu 10970190:538:661
status: NEW
view ABCC7 p.Phe693Leu details
These have been reported in patients with presenting phenotypes ranging from "cystic fibrosis" to oligospermia, but there have been too few cases Table 2 Compound heterozygotes detected Domain and mutation type Genotype Exon 1st IRT 2nd IRT Transmembrane, missense F508/P67L 3 129 34* F508/R117H 4 110 21* F508/R117H 4 84 34 F508/R117H 4 95 39 F508/R117H 4 104 40 F508/R117H 4 146 41 F508/R117H 4 104 48* F508/R117H 4 120 53 F508/R117H 4 111 54 F508/R117H 4 175 72* F508/R117L 4 129 70 F508/L967S 15 122 15 F508/F1052V 17b 189 29 F508/R1066H 17b 94 18 Transmembrane, nonsense F508/R75X 3 86 26 F508/R75X 3 171 27 F508/R851X 14a 112 76 Regulatory, missense F508/F693L 13 109 29 Alternate splice site F508/3849+10KB C→T i19 99 26* F508/3849+10KB C→T i19 112 36* None of these samples had the IVS8-5T variant sequence. Login to comment
543 ABCC7 p.Phe693Leu
X
ABCC7 p.Phe693Leu 10970190:543:22
status: NEW
view ABCC7 p.Phe693Leu details
The missense mutation F693L is located in the regulatory domain of CFTR and was first identified in a young girl with F508 on her other allele who was diagnosed with pancreatic insuYcient cystic fibrosis.26 Three subjects had nonsense mutations which are normally associated with severe disease as they introduce a stop codon, leading to truncated, usually inactive, CFTR protein being transcribed. Login to comment